Browse

GB

“Glow” blend

Recovery & Tissue Research

Research uses Research-library note is missing for this catalog SKU. Fill in mechanism, key points, and literature references.

LIMITED RESEARCH →

5A1

5-Amino-1MQ

NNMT inhibitor · metabolic & NAD+ research

NNMT inhibition in metabolic models NAD+ salvage pathway research Mitochondrial and insulin-sensitivity readouts

Research uses NAD+ availability after NNMT block · Mitochondrial function markers · Adipocyte size and insulin-sensitivity assays

CORE →

5A1

5-Amino-1MQ

NNMT inhibitor · metabolic & NAD+ research

NNMT inhibition in metabolic models NAD+ salvage pathway research Mitochondrial and insulin-sensitivity readouts

Research uses NAD+ availability after NNMT block · Mitochondrial function markers · Adipocyte size and insulin-sensitivity assays

CORE →

A

Adipotide

Prohibitin-targeting peptide (CKGGRAKDC-GG-D(KLAKLAK)2)

Targeted pro-apoptotic peptide Adipose-vasculature homing Not an approved therapy

Research uses White-fat vasculature targeting

ANIMAL / EARLY HUMAN ATTEMPT →

A

Adipotide

Prohibitin-targeting peptide (CKGGRAKDC-GG-D(KLAKLAK)2)

Targeted pro-apoptotic peptide Adipose-vasculature homing Not an approved therapy

Research uses White-fat vasculature targeting

ANIMAL / EARLY HUMAN ATTEMPT →

A

AOD9604

HGH fragment 176–191

hGH C-terminal fragment Lipolysis-focused design Limited late-stage success

Research uses Lipolysis without IGF-1 rise (design goal)

PRECLINICAL + MIXED TRIALS →

AF1

AOD9604 (Fragment 176-191)

HGH fragment 176–191

hGH C-terminal fragment Lipolysis-focused design Limited late-stage success

Research uses Lipolysis without IGF-1 rise (design goal)

PRECLINICAL + MIXED TRIALS →

A2

ARA-290

Cibinetide · EPO-receptor innate-repair peptide

Non-hematopoietic EPO analogue Innate repair receptor Neuropathy trial history

Research uses Small-fiber / sarcoidosis neuropathy papers

CLINICAL-EXPERIMENTAL →

A2

ARA-290

Cibinetide · EPO-receptor innate-repair peptide

Non-hematopoietic EPO analogue Innate repair receptor Neuropathy trial history

Research uses Small-fiber / sarcoidosis neuropathy papers

CLINICAL-EXPERIMENTAL →

B1

BPC-157

Gastric pentadecapeptide · tissue-repair research

Pentadecapeptide (15 aa) Angiogenesis and tendon/ligament models GI mucosal protection papers

Research uses Tendon, ligament, and muscle injury assays · NSAID and fistula-type models in animals

EXTENSIVE PRECLINICAL →

B1

BPC-157

Gastric pentadecapeptide · tissue-repair research

Pentadecapeptide (15 aa) Angiogenesis and tendon/ligament models GI mucosal protection papers

Research uses Tendon, ligament, and muscle injury assays · NSAID and fistula-type models in animals

EXTENSIVE PRECLINICAL →

B1T

BPC-157 + TB-500 blend

Gastric pentadecapeptide · tissue-repair research

Pentadecapeptide (15 aa) Angiogenesis and tendon/ligament models GI mucosal protection papers

Research uses Tendon, ligament, and muscle injury assays · NSAID and fistula-type models in animals

EXTENSIVE PRECLINICAL →

C

Cagrilintide

Long-acting amylin analogue

Amylin receptor agonist Satiety and gastric-emptying models Combination literature with incretins

Research uses Standalone and incretin combination studies

CLINICAL PROGRAMS →

C

Cagrilintide

Long-acting amylin analogue

Amylin receptor agonist Satiety and gastric-emptying models Combination literature with incretins

Research uses Standalone and incretin combination studies

CLINICAL PROGRAMS →

C

Cerebrolysin

Porcine brain peptide mixture

Peptide hydrolysate Neurotrophic-mimetic literature Regional registered drug exists

Research uses Heterogeneous evidence quality

REGIONAL TRIALS →

C

Cerebrolysin

Porcine brain peptide mixture

Peptide hydrolysate Neurotrophic-mimetic literature Regional registered drug exists

Research uses Heterogeneous evidence quality

REGIONAL TRIALS →

CIB

CJC & IPA BLEND

Growth & Body Research

Research uses Research-library note is missing for this catalog SKU. Fill in mechanism, key points, and literature references.

LIMITED RESEARCH →

C1

CJC-1295

GHRH analogue (DAC and non-DAC forms)

GHRH(1-29) analogue DAC vs non-DAC kinetics GH/IGF-1 axis research

Research uses Sustained IGF-1 in DAC papers

PHARMACOLOGY →

C1W

CJC-1295 with DAC

GHRH analogue (DAC and non-DAC forms)

GHRH(1-29) analogue DAC vs non-DAC kinetics GH/IGF-1 axis research

Research uses Sustained IGF-1 in DAC papers

PHARMACOLOGY →

C1W

CJC-1295 without DAC

GHRH analogue (DAC and non-DAC forms)

GHRH(1-29) analogue DAC vs non-DAC kinetics GH/IGF-1 axis research

Research uses Sustained IGF-1 in DAC papers

PHARMACOLOGY →

D

DSIP

Delta sleep-inducing peptide

Sleep-research nonapeptide Mixed clinical-history data Stress-axis papers

Research uses Delta-wave literature

HISTORICAL →

D

DSIP

Delta sleep-inducing peptide

Sleep-research nonapeptide Mixed clinical-history data Stress-axis papers

Research uses Delta-wave literature

HISTORICAL →

E

Epithalon

Ala-Glu-Asp-Gly tetrapeptide · pineal research

Pineal tetrapeptide Gerontology research history Limited modern RCT evidence

Research uses Telomerase and pineal papers

HISTORICAL PRECLINICAL →

EE

Epithalon (Epitalon)

Ala-Glu-Asp-Gly tetrapeptide · pineal research

Pineal tetrapeptide Gerontology research history Limited modern RCT evidence

Research uses Telomerase and pineal papers

HISTORICAL PRECLINICAL →

GC

GHK-Cu

Copper tripeptide · skin & remodeling research

Tripeptide–copper complex Extracellular matrix gene expression Cosmetic-research and wound models

Research uses Collagen and remodeling transcripts · SOD and related pathways in fibroblast papers

WELL DESCRIBED IN VITRO →

GC

GHK-Cu

Copper tripeptide · skin & remodeling research

Tripeptide–copper complex Extracellular matrix gene expression Cosmetic-research and wound models

Research uses Collagen and remodeling transcripts · SOD and related pathways in fibroblast papers

WELL DESCRIBED IN VITRO →

G6

GHRP-6

Met-enkephalin-derived GH secretagogue

First-generation GHRP GHSR / appetite models Less selective than ipamorelin

Research uses Ghrelin-mimetic behavior in animals

CLASSIC →

G6

GHRP-6

Met-enkephalin-derived GH secretagogue

First-generation GHRP GHSR / appetite models Less selective than ipamorelin

Research uses Ghrelin-mimetic behavior in animals

CLASSIC →

H

Hexarelin

GHRP hexapeptide

GHRP-6 analogue family GH + ACTH/prolactin signal Cardiac GHSR/CD36 papers

Research uses Robust GH pulses · GHSR/CD36 literature

CLASSIC →

H

Hexarelin

GHRP hexapeptide

GHRP-6 analogue family GH + ACTH/prolactin signal Cardiac GHSR/CD36 papers

Research uses Robust GH pulses · GHSR/CD36 literature

CLASSIC →

I

Ipamorelin

Selective GHSR / GHRP analogue

Ghrelin-receptor agonist Pulsatile GH release models Lower ACTH signal vs older GHRPs (literature)

Research uses Selective GH release assays

CLASSIC PHARMACOLOGY →

I

Ipamorelin

Selective GHSR / GHRP analogue

Ghrelin-receptor agonist Pulsatile GH release models Lower ACTH signal vs older GHRPs (literature)

Research uses Selective GH release assays

CLASSIC PHARMACOLOGY →

K1

Kisspeptin-10

Kp-10 · GnRH-axis peptide

KISS1R agonist fragment GnRH/LH pulse research Reproductive-axis probe

Research uses LH stimulation studies

STRONG HUMAN EXPERIMENTAL →

K1

Kisspeptin-10

Kp-10 · GnRH-axis peptide

KISS1R agonist fragment GnRH/LH pulse research Reproductive-axis probe

Research uses LH stimulation studies

STRONG HUMAN EXPERIMENTAL →

KB

KLOW Blend

Skin & Beauty Research

Research uses Research-library note is missing for this catalog SKU. Fill in mechanism, key points, and literature references.

LIMITED RESEARCH →

K

KPV

α-MSH anti-inflammatory tripeptide

α-MSH fragment NF-κB / inflammatory models Skin and gut research

Research uses Colitis and skin inflammation models

PRECLINICAL →

K

KPV

α-MSH anti-inflammatory tripeptide

α-MSH fragment NF-κB / inflammatory models Skin and gut research

Research uses Colitis and skin inflammation models

PRECLINICAL →

MI

Melanotan II

Non-selective melanocortin agonist

α-MSH analogue MC1R pigmentation Central melanocortin effects

Research uses Melanogenesis

PRECLINICAL / UNOFFICIAL USE LITERATURE →

MI

Melanotan II

Non-selective melanocortin agonist

α-MSH analogue MC1R pigmentation Central melanocortin effects

Research uses Melanogenesis

PRECLINICAL / UNOFFICIAL USE LITERATURE →

MC

MOTS-c

Mitochondrial-encoded 16-aa peptide

Mitochondrial ORF peptide AMPK-related metabolic models Stress-responsive nuclear translocation

Research uses Aged and diet-challenge models · Metabolic flexibility papers

MOUSE →

MC

MOTS-c

Mitochondrial-encoded 16-aa peptide

Mitochondrial ORF peptide AMPK-related metabolic models Stress-responsive nuclear translocation

Research uses Aged and diet-challenge models · Metabolic flexibility papers

MOUSE →

N

NAD+

Nicotinamide adenine dinucleotide

Redox cofactor Sirtuin / PARP substrate Longevity-adjacent literature

Research uses TCA, ETC, and signaling consumption

FOUNDATIONAL BIOCHEMISTRY →

N

NAD+

Nicotinamide adenine dinucleotide

Redox cofactor Sirtuin / PARP substrate Longevity-adjacent literature

Research uses TCA, ETC, and signaling consumption

FOUNDATIONAL BIOCHEMISTRY →

O

Oxytocin

Nonapeptide hormone

Endogenous nonapeptide OXTR signaling Licensed drugs exist separately

Research uses IN oxytocin cognition studies · Smooth muscle

LARGE EXPERIMENTAL →

OA

Oxytocin acetate

Nonapeptide hormone

Endogenous nonapeptide OXTR signaling Licensed drugs exist separately

Research uses IN oxytocin cognition studies · Smooth muscle

LARGE EXPERIMENTAL →

PM

PEG-MGF

Pegylated mechano growth factor

IGF-1 splice analogue Muscle-load biology Pegylated research reagent

Research uses Load-induced IGF-1Ec literature

PRECLINICAL →

PM

PEG-MGF

Pegylated mechano growth factor

IGF-1 splice analogue Muscle-load biology Pegylated research reagent

Research uses Load-induced IGF-1Ec literature

PRECLINICAL →

P1

PT-141

Bremelanotide · melanocortin agonist

Melanocortin agonist CNS sexual-function literature Licensed drug exists separately

Research uses HSDD trials of bremelanotide

APPROVED INDICATION (DRUG) →

P1B

PT-141 (Bremelanotide)

Bremelanotide · melanocortin agonist

Melanocortin agonist CNS sexual-function literature Licensed drug exists separately

Research uses HSDD trials of bremelanotide

APPROVED INDICATION (DRUG) →

R

Retatrutide

Triple GIP/GLP-1/glucagon agonist · metabolic research

Triple incretin/glucagon pharmacology Metabolic-trial literature Research-use catalog item only

Research uses Body-weight and metabolic endpoints in NEJM 2023 · Glucose-related secondary measures

PHASE 2 PUBLISHED →

R

Retatrutide

Triple GIP/GLP-1/glucagon agonist · metabolic research

Triple incretin/glucagon pharmacology Metabolic-trial literature Research-use catalog item only

Research uses Body-weight and metabolic endpoints in NEJM 2023 · Glucose-related secondary measures

PHASE 2 PUBLISHED →

S

Selank

Tuftsin analogue · anxiolytic research peptide

Tuftsin analogue Anxiolytic models Immune-modulation papers

Research uses Anxiety-like behavior assays

PRECLINICAL + REGIONAL TRIALS →

S

Selank

Tuftsin analogue · anxiolytic research peptide

Tuftsin analogue Anxiolytic models Immune-modulation papers

Research uses Anxiety-like behavior assays

PRECLINICAL + REGIONAL TRIALS →

S

Semaglutide

GLP-1 receptor agonist

Selective GLP-1 agonist Long plasma half-life vs native GLP-1 STEP / SUSTAIN clinical programs (licensed drug)

Research uses Glycemia and weight endpoints in licensed-drug trials

VERY LARGE →

S

Semaglutide

GLP-1 receptor agonist

Selective GLP-1 agonist Long plasma half-life vs native GLP-1 STEP / SUSTAIN clinical programs (licensed drug)

Research uses Glycemia and weight endpoints in licensed-drug trials

VERY LARGE →

S

Semax

ACTH(4-10) analogue · cognitive research

ACTH fragment analogue BDNF-related papers Stroke and cognitive models

Research uses Ischemia and cognitive assays

PRECLINICAL / REGIONAL →

S

Semax

ACTH(4-10) analogue · cognitive research

ACTH fragment analogue BDNF-related papers Stroke and cognitive models

Research uses Ischemia and cognitive assays

PRECLINICAL / REGIONAL →

S

Sermorelin

GHRH(1-29) amide

Native-length GHRH fragment Diagnostic-history molecule Short GH pulse

Research uses GH stimulation tests

HISTORICAL CLINICAL →

S

Sermorelin

GHRH(1-29) amide

Native-length GHRH fragment Diagnostic-history molecule Short GH pulse

Research uses GH stimulation tests

HISTORICAL CLINICAL →

SP3

SLU-PP-332

ERR pan-agonist · exercise-mimetic research

ERR pan-agonist (small molecule) Exercise-mimetic phenotype in mice Metabolic and cardiac-research interest

Research uses Running capacity and oxidative-fiber papers

MOUSE →

SP3

SLU-PP-332

ERR pan-agonist · exercise-mimetic research

ERR pan-agonist (small molecule) Exercise-mimetic phenotype in mice Metabolic and cardiac-research interest

Research uses Running capacity and oxidative-fiber papers

MOUSE →

S3

SS-31

Elamipretide · mitochondrial inner membrane

Cardiolipin-targeted tetrapeptide Bioenergetics assays Clinical-development molecule exists separately

Research uses Mitochondrial disease and cardiac programs

EXTENSIVE PRECLINICAL + TRIALS →

T5

TB-500

Thymosin β4 fragment · actin-binding research

Actin cytoskeleton Cell migration assays Soft-tissue models

Research uses Migration and angiogenesis readouts

PRECLINICAL →

T5T

TB-500 (Thymosin Beta-4)

Thymosin β4 fragment · actin-binding research

Actin cytoskeleton Cell migration assays Soft-tissue models

Research uses Migration and angiogenesis readouts

PRECLINICAL →

T

Tesamorelin

Stabilized GHRH analogue

Stabilized GHRH Visceral-fat trial literature (licensed drug) GH/IGF-1 axis

Research uses Visceral adipose endpoints

APPROVED INDICATION (DRUG PRODUCT) →

T

Tesamorelin

Stabilized GHRH analogue

Stabilized GHRH Visceral-fat trial literature (licensed drug) GH/IGF-1 axis

Research uses Visceral adipose endpoints

APPROVED INDICATION (DRUG PRODUCT) →

T

Thymalin

Thymic peptide complex

Thymic peptide complex Immune-aging literature Not the same as Tα1

Research uses T-cell phenotype papers

REGIONAL PRECLINICAL / CLINICAL-HISTORY →

T

Thymalin

Thymic peptide complex

Thymic peptide complex Immune-aging literature Not the same as Tα1

Research uses T-cell phenotype papers

REGIONAL PRECLINICAL / CLINICAL-HISTORY →

TA1

Thymosin Alpha-1

28-aa thymic peptide (Tα1)

Defined 28-mer Immune-modulation literature Licensed product exists separately

Research uses Vaccine adjuvant and infection-adjunct papers

CLINICAL (LICENSED DRUG) + RESEARCH →

TA1

Thymosin Alpha-1

28-aa thymic peptide (Tα1)

Defined 28-mer Immune-modulation literature Licensed product exists separately

Research uses Vaccine adjuvant and infection-adjunct papers

CLINICAL (LICENSED DRUG) + RESEARCH →

T

Tirzepatide

Dual GIP/GLP-1 agonist

Dual incretin agonist Large outcome programs (licensed molecule) RUO vials are not pharmacy stock

Research uses SURPASS program · SURMOUNT program

EXTENSIVE (LICENSED DRUG) →